MedPath

Efficacy of Preoperative Administration of Paracetamol-codeine on Pain Following Impacted Mandibular Third Molar Surgery

Phase 4
Completed
Conditions
To Control Pain After Third Molar Surgery
Interventions
Drug: Placebo Oral Tablet
Registration Number
NCT03049878
Lead Sponsor
University of Roma La Sapienza
Brief Summary

Objectives:

The aim of this study was to determine the effectiveness of preoperative administration of single-dose of paracetamol-codeine, in the relieving of acute post-operative pain after the surgical removal of an impacted mandibular third molar.

Materials and Methods:

The study cohort consisted of 32 Caucasian outpatients, giving a total of 64 bilateral symmetrical impacted mandibles. Patients were randomized in two experimental groups to receive a preoperative oral dose of paracetamol-codeine (analgesic group) or a placebo (placebo group) at the first and second surgeries. Study participants were asked to record pain intensity scores during the operation and the next 2 days, the time of the first request for rescue analgesic, and the total number of postoperative-supplement paracetamol-codeine tablets.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
32
Inclusion Criteria
  • absence of systemic pathologies (ASA class I);
  • non-smoker;
  • not pregnant or lactating;
  • good oral hygiene;
  • no drug consumption for 10 days before the operation;
  • bilateral impacted mandibular third molars with comparable position, depth and inclination;
  • presence of the first and second molars;
  • absence of painful symptoms and associated inflammatory or osteolytic pathologies in a radiographic examination;
  • extraction difficulty index of >7 according to Pederson's scale and a degree of IV (complex procedures) on a modified version of Parant's scale.
Exclusion Criteria

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
analgesic groupParacetamol Codeinepreoperative oral dose of paracetamol-codeine
placebo groupPlacebo Oral Tabletpreoperative placebo (starch)
Primary Outcome Measures
NameTimeMethod
Pain measurement assessed with the Numerical Rating Scale-11 (NRS-11) during the operative day.All study participants were asked to record the pain intensity score at 11:00 pm during the operative day

The primary outcome of the study was the post-operative pain. Before surgery, patients were instructed to complete the Numerical Rating Scale-11 (NRS-11), which consisted of an interval scale ranging from 0 ("no pain") to 10 ("maximum pain")

Pain measurement assessed with the Numerical Rating Scale-11 (NRS-11) during the 2th day after surgery.All study participants were asked to record the pain intensity score at 11:00 pm during the 2th day after surgery

The primary outcome of the study was the post-operative pain. Before surgery, patients were instructed to complete the Numerical Rating Scale-11 (NRS-11), which consisted of an interval scale ranging from 0 ("no pain") to 10 ("maximum pain")

Pain measurement assessed with the Numerical Rating Scale-11 (NRS-11) during the 3th day after surgery.All study participants were asked to record the pain intensity score at 11:00 pm during the 3th day after surgery

The primary outcome of the study was the post-operative pain. Before surgery, patients were instructed to complete the Numerical Rating Scale-11 (NRS-11), which consisted of an interval scale ranging from 0 ("no pain") to 10 ("maximum pain")

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath